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Abstract Hypoxia inducible factor 1 (HIF-1) is a heterodimer-
ic transcriptional complex that plays pivotal role in the regula-
tion of cellular utilization of oxygen as well as glucose and is an
essential regulator of angiogenesis in solid tumor and ischemic
disorders. Recently HIF-1K, a subunit of HIF-1 complex, was
characterized as a potential target for S-nitrosation, providing
no information about the impact of this posttranslational mod-
i¢cation on the protein transactivation. Cys-800 of HIF-1K pro-
tein has reactive SH-group, which is critical for the recruitment
of p300 co-activator that is necessary for transcriptional activity
of HIF-1 complex. Here we report that S-nitrosation of Cys-
800 activates HIF-1K^p300 interaction and stimulates protein
transactivation. We have found that S-nitrosation of the HIF-
1K C-terminal domain by nitric oxide derived from donors and
nitric oxide synthase increases protein transcriptional activity.
The increase of HIF-1 transcriptional activity was not observed
in the case of Cys-800 substitution to Ala, though other protein
thiol groups were nitrosated. Experiments with GST pull-down
assay suggest that S-nitrosation of Cys-800 stimulates the re-
cruitment of p300 co-activator protein to the HIF-1K C-termi-
nal domain.
. 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
1. Introduction
Hypoxia inducible factor 1 (HIF-1) is a heterodimeric tran-
scriptional activator, which consists of inducible K and con-
stitutive L subunits. HIF-1K was found to be a limiting factor
for HIF-1 transcriptional activity [1].
HIF-1 functions as a master regulator of cellular oxygen
homeostasis. It plays central role in development of and in
adaptation to hypoxia by directing the expression of genes
that promote angiogenesis, embryogenesis, erythropoiesis, tu-
morogenesis and vasodilatation. HIF-1K degradation is medi-
ated via its hydroxylation on Pro-402 and -564; proline-hy-
droxylation of HIF-1K allows it to bind the von Hippel^
Lindau tumor suppressor protein (pVHL), the recognition
component of a multiprotein E3 ubiquitin ligase complex
[2^4]. Complex formed from HIF-1K and pVHL recruits
also factor inhibiting HIF, which has recently been found to
hydroxylate Asn-803 preventing the HIF-1 transcriptional ac-
tivation through interaction with p300/CBP [5].
HIF-1K protein is stabilized by hypoxia as well as by the
major growth factor-stimulated signal transduction pathways
and redox-dependent mechanisms [6^8]. HIF-1K accumulating
e¡ect was also reported for the nitric oxide derived from dif-
ferent donors as well as enzymatically produced under nor-
moxic conditions [9^12]. Recently we found that nitrosation
of HIF-1K SH-groups correlates with the protein stabilization
in di¡erent cell lines [13]. Cys-800 of HIF-1K is known to be
critical for HIF-1 protein transactivation [14]. Substitution of
Cys-800 to the hydrophobic amino acid (valine) increases pro-
tein transcriptional activity. In the present work we report
that S-nitrosation of Cys-800 of HIF-1K protein leads to the
increase in HIF-1 transcriptional activity [15]. We found that
S-nitrosation of the HIF-1K transactivation domain by the
nitric oxide derived from donors and inducible nitric oxide
synthase (iNOS) increases protein transcriptional activity.
The increase of HIF-1 transcriptional activity was not ob-
served in the case of Cys-800 substitution to Ala, despite
that other protein SH-groups were nitrosated. Experiments
with a glutathione S-transferase (GST) pull-down assay sug-
gest that S-nitrosation of Cys-800 supports the recruitment of
p300 co-activator protein to the HIF-1K C-terminal domain.
2. Materials and methods
2.1. Materials
Medium and supplements were purchased from Biochrom (Berlin,
Germany). Fetal calf serum was bought from Life Technologies (Ber-
lin, Germany). For plasmid puri¢cation we used HiSpeed plasmid
puri¢cation Qiagen kit (Valencia, USA). To make substitutions in
the plasmid we used QuickChange0 site-directed mutagenesis kit. En-
zyme-labeled streptavidin was bought from Rockland (Gilbertsville,
USA). Methyl-methane-thiosulfonate (MMTS) and N-(6-[biotinami-
do])hexyl)-3P-(2P-pyridyldithio) propionamide (biotin-HPDP) were
purchased from Pierce (Rockville, USA). GSNO was synthesized as
previously described [16]. All other chemicals were of the highest
grade of purity and commercially available.
2.2. Cell culture
HEK293 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum, L-glutamine
(2 mM), penicillin (50 IU/ml) and streptomycin sulfate (50 Wg/ml)
[17]. Renal carcinoma cells (RCC) were grown in DMEM supple-
mented with 10% fetal calf serum, L-glutamine (2 mM), penicillin
(50 IU/ml) and streptomycin sulfate (50 Wg/ml) [18].
2.3. Plasmids
We used the plasmid, which encodes the chimeric protein contain-
ing C-terminal transactivation domain of HIF-1K fused to the Gal4
DNA-binding domain (Gal4DBD/HIF-1K 727-826). Also we used the
same plasmid with Asn-803 substituted to Ala [19]. Both plasmids
were provided by Dr. M. Whitelaw, Adelaide, Australia. The last
construct was also used for further substitutions. Cys-800 in its struc-
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ture was substituted to Ala using QuickChange0 site-directed muta-
genesis kit according to the manufacturer’s protocol.
2.4. Transfections
HEK-293 as well as RCC cells were plated at 2^3U105 cells/60-mm
dish 1 day before co-transfection with luciferase containing Gal4-re-
porter plasmid and Gal4DBD/HIF-1K 727-826 expression plasmids
using calcium-phosphate precipitation [10].
2.5. Western blot detection of the HIF-1K C-terminal fragment
HIF-1K was measured by Western blot [10,19]. Brie£y, cells were
incubated for the times indicated, washed two times with ice-cold
phosphate-bu¡ered saline (PBS), scraped o¡, lysed in 200 Wl of lysis
bu¡er (50 mM Tris^HCl, 5 mM EDTA, 150 mM NaCl, 0.5% Non-
idet-40, 1 mM PMSF, pH 8.0) and sonicated. After centrifugation
(17 000Ug, 15 min) the protein content in the supernatants was ana-
lyzed. Finally, 100 Wg of protein was added to the same volume of 2U
sample bu¡er (125 mM Tris^HCl, 2% sodium dodecyl sulfate (SDS),
10% glycerine, 1 mM dithiothreitol (DTT), 0.002% bromphenol blue,
pH 6.9) and boiled for 5 min. Proteins were resolved on 7.5% SDS^
polyacrylamide gels and blotted to nitrocellulose membrane. Molec-
ular weights were calibrated in proportion to the running distance of
rainbow markers. Transblots were washed twice with TBS (50 mM
Tris^HCl, 140 mM NaCl, pH 7.3) containing 0.1% Tween 20 before
blocking unspeci¢c binding with TBS plus 5% skim milk for 1 h. The
HIF-1K (1:1000 in TBS plus 5% milk) polyclonal antibody acting
against the C-terminal domain of the protein was added and incuba-
ted for 60 min at room temperature. Afterwards, nitrocellulose mem-
branes were washed ¢ve times for 15 min with TBS containing 0.1%
Tween 20. For protein detection, blots were incubated with goat sec-
ondary antibodies conjugated with horse radish peroxidase (1:1000 in
TBS plus 5% milk) for 60 min, followed by ECL detection.
2.6. Detection of S-nitrosothiols by Western analysis
Western blot analysis of protein S-nitrosothiols was performed as
previously described [13,20]. In brief, cells were washed two times with
ice-cold PBS. Lysis bu¡er (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM
EDTA and 0.5% NP-40) was added, cells were scraped o¡ and cen-
trifuged (10 000Ug, 10 min). Four volumes of blocking bu¡er (9 vol-
umes of HEN bu¡er plus 1 volume 25% SDS, 20 mM MMTS (from a
2 M stock prepared in dimethylformamide) was added to the 1 vol-
ume of the 10 000Ug supernatant and incubated for 20 min at 50‡C
with frequent vortexing. MMTS was then removed by protein precip-
itation with acetone. Biotin-HPDP (¢nal concentration of 2 mM) and
sodium ascorbate (1 Wl to reach a ¢nal concentration of 1 mM) were
added. After incubation for 1 h at 25‡C, SDS^polyacrylamide gel
electrophoresis (PAGE) sample bu¡er was added and the samples
were resolved by SDS^PAGE and transferred for immunoblotting.
Considering that cysteine biotinylation is reversible, SDS^PAGE sam-
ple bu¡er was prepared without reducing agents. Furthermore, to
prevent non-speci¢c reactions of biotin-HPDP, samples were not
boiled prior to electrophoresis. All steps preceding SDS^PAGE were
carried out in the dark. Immunoblots were washed twice with TBS
(140 mM NaCl, 50 mM Tris^HCl, pH 7.3) containing 0.1% Tween 20,
blocked to avoid unspeci¢c binding with TBS plus 5% skim milk for
1 h and incubated with enzyme (horse radish peroxidase)-labeled
streptavidin (1:500 in TBS plus 5% milk) for 1 h at room temperature.
Nitrocellulose membrane was washed ¢ve times for 5 min each with
TBS containing 0.1% Tween 20 prior to the detection of S-nitrosated
proteins by ECL development.
2.7. Preparation of the GST-p300CH1 construct for a pull-down assay
The construct was prepared as previously described [19]. In brief,
the GST-p300CH1 domain (amino acids 300 to 528) fusion protein
was expressed from pGEX-4T3/p300CH1 and puri¢ed from bacterial
extract by glutathione agarose. A whole cell extract (200 Wg) from
transfected cells was mixed with 2 Wg of glutathione-bound GST-
CH1 in binding 20 mM Tris^HCl bu¡er (pH 8.0) containing 150
mM NaCl, 0.1% NP40, 1 mM DTT, 2 WM EDTA, 20 WM ZnCl2
as well as protease inhibitors and incubated during 2 h at 4‡C with
gentle rotation. The beads were pelleted, washed three times with
binding bu¡er, and bound proteins were eluted for SDS^PAGE
with SDS sample bu¡er.
2.8. Quanti¢cation of NO release from GSNO
NO production was detected using the oxyhaemoglobin assay [21].
2.9. Nitrite measurements
The concentration of nitrite was determined by the Griess assay
[22].
2.10. Protein quanti¢cation
The amount of protein was measured by the Bradford method [23].
2.11. Statistical analysis
Each experiment was performed at least three times and statistical
analysis was done using the two-tailed Student’s t-test. The statistical
probability (P) was expressed as *P6 0.01. The normal distribution of
data was checked.
3. Results and discussion
3.1. S-nitrosation of the HIF-1K Cys-800 leads to the increase
in protein transcriptional activity
S-nitrosation of protein thiol groups by nitric oxide is a
widely recognized protein modi¢cation [24]. Only few intra-
cellular S-nitrosated proteins have been identi¢ed and it has
been reported that S-nitrosation can serve as a regulatory
process in signal transduction pathways [25]. As we recently
reported HIF-1K protein can be considered as a target for
S-nitrosation, which correlates with protein stabilization in a
straight manner [13]. Cys-800 of HIF-1K protein has the re-
active thiol group, which is of major importance for the p300
Fig. 1. GSNO treatment of HEK293 cells leads to S-nitrosation of
the HIF-1K C-terminal domain, increasing its transcriptional activ-
ity. HEK293 cells were co-transfected with WT and N803A
Gal4DBD/HIF-1K 727-826 as well as Gal4 response element-driven
luciferase reporter gene using calcium phosphate precipitation. After
transfection cells were incubated for 24 h followed by 8 h of stimu-
lation with 1 mM GSNO. In 8 h cells were harvested and the lucif-
erase activity was assayed by the luminometric method (A). We also
used parallel cell treatments to detect the HIF-1K C-terminal frag-
ment as well as its S-nitrosation by Western analysis as outlined in
Section 2. To verify equal loading of the protein we used actin
staining (B). Digital data are mean valuesT S.D. of at least ¢ve in-
dividual experiments. *P6 0.01 vs. control. All Western blot data
are from one experiment representative of three that gave similar re-
sults.
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recruitment [15]. We asked whether S-nitrosation of the Cys-
800 leads to the increase in HIF-1 transcriptional activity. In a
¢rst set of experiments we co-transfected HEK293 cells with
Gal4DBD/HIF-1K 727-826 (wild-type or WT and mutated
plasmid, where Asn-803 is substituted to Ala or N803A) en-
coding plasmid and luciferase containing Gal4 reporter plas-
mid [19]. Cells were incubated for 24 h after transfection fol-
lowed by 8 h of stimulation with 1 mM GSNO. The rate of
NO release from GSNO was 299T 1.5 based on the oxyhae-
moglobin assay (t1=2 of this compound at 37‡C corresponds to
80 h) [26,27]. In 8 h cells were harvested and luciferase activity
was detected by luminometric method. GSNO treatment
caused the increase in the luciferase activity in the WT
GalDBD/HIF-1K 727-826 plasmid containing cells compared
to the co-transfected in the same manner but not stimulated
cells (Fig. 1A). The activity of luciferase was signi¢cantly in-
creased in non-treated N803A GalDBD/HIF-1K 727-826 plas-
mid containing cells compared to the non-stimulated WT
GalDBD/HIF-1K 727-826 plasmid containing cells. Treatment
of these cells with GSNO caused further increase in the lucif-
erase activity (Fig. 1A). Asn-803 is the only target for degres-
sive hydroxylation of the HIF-1K C-terminal fragment. The
results obtained by luciferase assay are consistent with the
Western blot data (Fig. 1B). Transfected construct is detect-
able in the transfected cells. Its S-nitrosation was observed in
the transfected and GSNO-stimulated cells. Equal loading of
the protein is veri¢ed by actin staining. If we assume that the
increase in the luciferase activity is the result of the NO-de-
pendent inhibition of HIF-1K proline hydroxylation, this hy-
pothesis will work only for the WT plasmid, because the
N803A construct has no targets to be hydroxylated [19].
Then we can hypothesize that protein S-nitrosation is the
reason for the increase in its transcriptional activity. C-termi-
nal fragment of HIF-1K protein has three SH-groups, how-
ever the thiol group of Cys-800 is quali¢ed as the reactive one
that is of major importance for the recruitment of co-activa-
tors. These data allow to predict that nitrosation of Cys-800
SH-group leads to the increase of the protein transcriptional
activity. To con¢rm this hypothesis we substituted Cys-800 of
the N803A plasmid to Ala using QuickChange0 site-directed
mutagenesis kit. In the experimental set-up we co-transfected
N803A or C800A plasmid together with the luciferase con-
taining Gal4 reporter plasmid as described in the beginning of
this section. Stimulation of N803A containing cells with
GSNO resulted in increase in the transcriptional activity
(Fig. 2A), which is consistent with our previous data (see
Fig. 1A). Eight hours of treatment of the C800A plasmid
containing cells with GSNO resulted in the absence of tran-
scriptional activity increase (Fig. 2A). Both N803A and
C800A constructs were detectable in the cells by Western
blot. However C800A construct was characterized by lower
S-nitrosation compared to N803A (Fig. 2B). Equal loading of
the protein validated by actin staining. These data suggest
that S-nitrosation of the HIF-1K Cys-800 is critical for the
increase in the HIF-1 transcriptional activity. However this
e¡ect is demonstrated only upon GSNO-dependent S-nitro-
sation, which is an arti¢cial one.
3.2. Cytokine-dependent induction of NOS causes S-nitrosation
of the HIF-1K protein C-terminal fragment and increase in
its transcriptional activity
In the next set of experiments we examined the impact of
S-nitrosation of HIF-1K by nitric oxide derived from iNOS on
HIF-1 transactivation. We asked whether physiological in-
crease of the NO production (activation of iNOS) leads to
the increase in HIF-1 transcriptional activity. Our recent
data show that the whole HIF-1K protein is S-nitrosated
when the iNOS is activated by cytokines. However there is
no indication about the impact on the protein transactivation.
For these experiments we used RCC cells because it is impos-
sible to induce NOS activity in HEK293 cells. We co-trans-
fected the cells with WT or N803A GalDBD/HIF-1K 727-826
encoding plasmids together with the luciferase containing
Gal4 reporter plasmid. Cells were incubated for 24 h after
transfection followed by 24 h of stimulation with cytokine
mix (75 U/ml IL-1L, 250 U/ml IFN-Q, 25 Wg/ml LPS) [28].
To con¢rm the involvement of NOS we blocked NO forma-
tion by N-monomethyl-L-arginine (NMMA), which revealed
no major impact by itself [13]. In 24 h nitrite content was
detected in the cell culture medium, the cells were harvested
for the luciferase activity assay. Cytokine treatment of the
RCC cells caused an increase in nitrite content con¢rming
NOS activation (Fig. 3). This resulted in the S-nitrosation
of the HIF-1K C-terminal fragment correlating with the tran-
scriptional activation of both WT and N803A proteins
Fig. 2. Substitution of Cys-800 in the HIF-1K C-terminal domain to
Ala attenuates S-nitrosation-dependent activation of the protein
transcriptional activity. HEK293 cells were co-transfected with
N803A and C800A Gal4DBD/HIF-1K 727-826 as well as Gal4 re-
sponse element-driven luciferase reporter gene using calcium phos-
phate precipitation. After transfection cells were incubated for 24 h
followed by 8 h of stimulation with 1 mM GSNO. In 8 h cells were
harvested and the luciferase activity was assayed by the luminomet-
ric method (A). We also used parallel cell treatments to detect the
HIF-1K C-terminal fragment as well as its S-nitrosation by Western
analysis as described in Section 2. To verify equal loading of the
protein we used actin staining (B). Digital data are mean val-
ues T S.D. of at least ¢ve individual experiments. *P6 0.01 vs. con-
trol. All Western blot data are from one experiment representative
of three that gave similar results.
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(Fig. 3). Blockage of nitrite formation by the NMMA nulli¢ed
S-nitrosation and attenuated the increase in transcriptional
activity suggesting the involvement of a NOS, while
NMMA by its own revealed no major impact (Fig. 3).
3.3. Nitrosation of Cys-800 of HIF-1K protein supports its
interaction with p300 co-activator protein
Recent data suggest that substitution of HIF-1K Cys-800 to
valine increases HIF-1 transcriptional activity by the activa-
tion of HIF-1K^p300 interactions [14]. S-NO group is char-
acterized by the equal distribution of the electron density,
which makes the group to develop hydrophobic mimicking
activity and allows the assumption that S-nitrosation of
Cys-800 supports HIF-1K^p300 interaction. The HIF-1K
C-terminal domain functions by recruiting transcriptional
co-activator p300/CBP, which directly interacts with it via
its CH1 domain. To examine the impact of nitric oxide on
the HIF-1K^p300 interaction we used recombinant GST-CH1
in GST pull-down experiments with the protein extracts from
cells transiently transfected with the constructs expressing the
HIF-1K C-terminal region (in this experimental set-up we
used only N803A and C800A plasmids). Whole cell extracts
obtained from non-stimulated cells as well as from cells ex-
posed to 1 mM GSNO for 8 h were mixed with recombinant
GST-p300CH1 (amino acids 300 to 528) in a pull-down assay.
Aliquots of the whole cell extracts (20% of input) and 50% of
the GST-CH1 pull-down were separated by SDS^PAGE and
the HIF-1K C-terminal domain was detected by Western blot
using polyclonal antibody directed against HIF-1K C-termi-
nus [19]. S-nitrosation of the HIF-1K C-terminal fragment
was also detected. We found that S-nitrosation of the
N803A construct correlated with the increase in binding to
p300CH1 (Fig. 4), however S-nitrosation of C800A protein
resulted in no increase. These results suggest that S-nitrosa-
tion of Cys-800 of HIF-1K protein supports its interaction
with p300 co-activator protein.
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